Frank Litvack
Chairman chez CAPRICOR THERAPEUTICS, INC.
Fortune : 904 897 $ au 31/03/2024
Profil
Frank Litvack is the founder of iTherX Pharmaceuticals, Inc. (founded in 1992), Progressive Angioplasty Systems, Inc. (founded in 1989), Savacor, Inc. (founded in 2000), Conor Medsystems LLC (founded in 2002), Fasturn, Inc. (founded in 1999), TrialTech Medical, Inc. (founded in 2018), and VIDA FLaSH Acquisitions (founded in 2021).
He held various titles at these companies, including Director, Chairman & Chief Executive Officer, and Chief Executive Officer & Director.
Dr. Litvack was also the founder of Advanced Interventional Systems, Inc., Pura Vida Investments LLC, and Levation Pharma Ltd.
His current job(s).
included Executive Chairman at Capricor, Inc. (since 2012), Chairman at Credence MedSystems, Inc., Chairman at V-Wave Ltd., Executive Chairman at Capricor Therapeutics, Inc. (since 2012), Director at Cardiovascular Research Foundation, Director at Tanenbaum Open Science Institute, Professor at the University of California, Los Angeles, Member at the University of California, Davis, Member at Calmedica LLC (since 1985), Member at.
Pura Vida Investments LLC (Private Equity), and Member at Wilhareka Partners LLC (since 2020).
His former job(s) include Director at One Lambda, Inc., Director at ReCor Medical, Inc., Director at CathWorks Ltd., Co-Director at Cardiovascular Intervention Center, Director at MedAvail, Inc., Director at MedAvail Holdings, Inc., and Principal at Cedars-Sinai Medical Center (from 1989 to 1997).
Dr. Litvack's education includes undergraduate and doctorate degrees from McGill University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 18/03/2024 | 133 269 ( 0,42% ) | 904 897 $ | 31/03/2024 |
Postes actifs de Frank Litvack
| Sociétés | Poste | Début |
|---|---|---|
| CAPRICOR THERAPEUTICS, INC. | Chairman | 01/11/2013 |
| University of California, Los Angeles | Corporate Officer/Principal | - |
Pura Vida Investments LLC (Private Equity)
 Pura Vida Investments LLC (Private Equity) Investment ManagersFinance Pura Vida Investments LLC (Private Equity) is a private equity subsidiary of Pura Vida Investments LLC founded in 2012. The firm is headquartered in New York. | Private Equity Investor | - |
Pura Vida Investments LLC
 Pura Vida Investments LLC Investment ManagersFinance Pura Vida Investments LLC (Pura Vida) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded in 2012 by Efrem Kamen, Frank Litvack and Doron Junger. Pura Vida provides discretionary investment advisory services to private pooled investment vehicles, intended for institutional and other sophisticated investors, pooled investment vehicles the firm sub-advises, and managed accounts. | Founder | - |
| Tanenbaum Open Science Institute | Director/Board Member | - |
VIDA FLaSH Acquisitions
 VIDA FLaSH Acquisitions Financial ConglomeratesFinance VIDA FLaSH Acquisitions operates as a development stage company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded by Frank Litvack and Scott R. Huennekens on January 29, 2021 and is headquartered in Los Angeles, CA. | Founder | 29/01/2021 |
Credence MedSystems, Inc.
 Credence MedSystems, Inc. Medical DistributorsDistribution Services Credence MedSystems, Inc. engages in drug delivery and pharmaceutical services. Its products include companion staked needle, luer and dual chamber reconstitution safety syringes. The company was founded by John F. Shanley and is headquartered in Menlo Park, CA. | Chairman | - |
V-Wave Ltd.
 V-Wave Ltd. Electronic Equipment/InstrumentsElectronic Technology V-Wave Ltd. engages in the development of implantable medical device for treating chronic heart failure. It offers V-Wave Shunt, which is a biocompatible inter-atrial unidirectional implant. The company was founded by Gad Keren and Yaacov Nitzan in 2009 and is headquartered in Caesarea, Israel. | Chairman | - |
Capricor, Inc.
 Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a private company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | Chairman | 01/11/2013 |
| ░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Frank Litvack
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Frank Litvack
| McGill University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MEDAVAIL HOLDINGS, INC. | Health Technology |
| CAPRICOR THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 23 |
|---|---|
iTherX Pharmaceuticals, Inc.
 iTherX Pharmaceuticals, Inc. Medical DistributorsDistribution Services iTherX is a clinical stage pharmaceutical company focused on the discovery and development of innovative treatments for Hepatitis C. This is a disease that affects almost 3% of the world's population, and is the major cause of chronic liver disease, cirrhosis, liver failure and primary liver cancer. Currently there is only a single mode of therapy and less than 5% of patients can be successfully treated. The company continues to carry out focused research in their areas of expertise to provide sustainability of product pipelines. In an era of managed care and increased regulatory scrutiny, it is easy to yield to the temptation of producing 'me too drugs'. However, they think that innovation in the development of pharmaceutical products is important because it is the only way to improve the outcomes for patients. As such, they also think that innovation can ensure the financial returns that investors in health care deserve for the risks that they take. Their innovative approach is evident in their pipeline of Hepatitis C drug candidates. As new and better treatments are being sought, most companies involved in this effort are targeting the enzymes responsible for viral replication: polymerases and proteases. While these are important targets, there is a great deal of duplication of effort in these initiatives. At iTherX, they are pioneering the development of a novel class of HCV antivirals by targeting the steps involved in the entry of the hepatitis C virus into liver cells. Their Host Cell Receptor Target Program engenders small molecule compounds that target a liver cell membrane protein, SR-B1, which recognize and dock the virus. Their lead compound, ITX5061, has extensive safety data in over 250 patients, and shows picomolar potency in inhibiting HCV infection in vitro. They plan to initiate a Phase 2a clinical trial in HCV patients in Q2 of 2009. They have also used medicinal chemistry to develop back-up compounds for this program, and a clinical candidate has been selected for development. Another innovative program is novel cell receptor, which develops antagonists (including biologics) against a novel liver cell membrane protein required for infectivity of the virus. | Distribution Services |
Progressive Angioplasty Systems, Inc.
 Progressive Angioplasty Systems, Inc. Medical SpecialtiesHealth Technology Part of Medtronic Plc, Progressive Angioplasty Systems, Inc. is a private company that makes and develops stents and stent technologies. The company is based in Menlo Park, CA. The company was founded by Frank Litvak, Frank Litvack. Progressive Angioplasty Systems was acquired by United States Surgical Corp. on September 23, 1997 for $150 million. | Health Technology |
Savacor, Inc.
 Savacor, Inc. Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Savacor, Inc. develops implantable medical devices for chronic congestive heart failure (CHF). The private company is based in Los Angeles, CA. The company was founded by Frank Litvack. Savacor was acquired by St. Jude Medical LLC, part of Abbott Laboratories from January 05, 2017 on January 03, 2006 for $50 million. | Health Technology |
Conor Medsystems LLC
 Conor Medsystems LLC Medical SpecialtiesHealth Technology Conor Medsystems LLC develops vascular drug delivery technologies. Its products include controlled vascular drug delivery technologies and novel stent that are used in the treatment of coronary artery disease and delivery of a broad spectrum of therapeutic agents. The company was founded by John F. Shanley in 1999 and is headquartered in Menlo Park, CA. | Health Technology |
Capricor, Inc.
Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a private company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | Health Technology |
Credence MedSystems, Inc.
Credence MedSystems, Inc. Medical DistributorsDistribution Services Credence MedSystems, Inc. engages in drug delivery and pharmaceutical services. Its products include companion staked needle, luer and dual chamber reconstitution safety syringes. The company was founded by John F. Shanley and is headquartered in Menlo Park, CA. | Distribution Services |
Cedars-Sinai Medical Center
 Cedars-Sinai Medical Center Hospital/Nursing ManagementHealth Services Cedars-Sinai Medical Center operates a hospital that provides healthcare services. It specializes in cancer, endocrinology, gynecology, neurology, orthopedics, and respiratory disorders. The company was founded in 1902 and is headquartered in Los Angeles, CA. | Health Services |
Fasturn, Inc.
 Fasturn, Inc. Packaged SoftwareTechnology Services Fasturn, Inc. provides web-based sourcing solutions. The company is based in Los Angeles, CA. The company was founded by Frank Litvack. | Technology Services |
Advanced Interventional Systems, Inc.
 Advanced Interventional Systems, Inc. Medical SpecialtiesHealth Technology Advanced Interventional Systems, Inc. manufactures surgical lasers. The company is based in Irvine, CA. The company was founded by Frank Litvack, Roger J. Guidi. Advanced Interventional Systems was acquired by Spectranetics LLC, part of Koninklijke Philips NV from August 10, 2017 on June 13, 1994. | Health Technology |
Cardiovascular Research Foundation
 Cardiovascular Research Foundation Miscellaneous Commercial ServicesCommercial Services The Cardiovascular Research Foundation operates as a civic and social association. The non-profit company is based in New York, NY. The company was founded by Charles A. Simonton. | Commercial Services |
One Lambda, Inc.
 One Lambda, Inc. Electronic Equipment/InstrumentsElectronic Technology One Lambda, Inc. provides transplantation services. The firm offers antibody detection, serology, molecular typing instruments and software products. The company was founded by Paul I. Terasaki in 1984 and is headquartered in Canoga Park, CA. | Electronic Technology |
| Calmedica LLC | |
ReCor Medical, Inc.
 ReCor Medical, Inc. Pharmaceuticals: MajorHealth Technology ReCor Medical, Inc. develops novel therapeutic ultrasound catheter technologies The firm develops a therapeutic non-focused ultrasound system for performing renal denervation in patients with resistant hypertension. The company was founded by Mano Iyer and Jacques Seguin in July 2009 and is headquartered in Palo Alto, CA. | Health Technology |
Pura Vida Investments LLC
Pura Vida Investments LLC Investment ManagersFinance Pura Vida Investments LLC (Pura Vida) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded in 2012 by Efrem Kamen, Frank Litvack and Doron Junger. Pura Vida provides discretionary investment advisory services to private pooled investment vehicles, intended for institutional and other sophisticated investors, pooled investment vehicles the firm sub-advises, and managed accounts. | Finance |
V-Wave Ltd.
V-Wave Ltd. Electronic Equipment/InstrumentsElectronic Technology V-Wave Ltd. engages in the development of implantable medical device for treating chronic heart failure. It offers V-Wave Shunt, which is a biocompatible inter-atrial unidirectional implant. The company was founded by Gad Keren and Yaacov Nitzan in 2009 and is headquartered in Caesarea, Israel. | Electronic Technology |
CathWorks Ltd.
 CathWorks Ltd. Medical SpecialtiesHealth Technology CathWorks Ltd. develops medical devices for the interventional cardiology market. Its technology is based on processing visual information and automatic multi-layered algorithms. The company was founded by Guy Lavi and Ifat Lavi in 2013 and is headquartered in Raanana, Israel. | Health Technology |
Pura Vida Investments LLC (Private Equity)
Pura Vida Investments LLC (Private Equity) Investment ManagersFinance Pura Vida Investments LLC (Private Equity) is a private equity subsidiary of Pura Vida Investments LLC founded in 2012. The firm is headquartered in New York. | Finance |
| Cardiovascular Intervention Center | |
TrialTech Medical, Inc.
 TrialTech Medical, Inc. Packaged SoftwareTechnology Services Part of Scarritt Group, Inc., TrialTech Medical, Inc. is a private company that provides subject recruitment services for clinical trials using targeted, AI-enabled digital marketing and a software platform that facilitates the activities of all stakeholders. The company is based in Beverly Hills, CA and was founded in 2018 by Harrison Litvack, William Litvack, and Frank Litvack. The company uses state-of-the-art technology to expand trial awareness, including outreach to underrepresented patient populations. Harrison Litvack has been the CEO since 2018. TrialTech Medical was acquired by Scarritt Group, Inc. on January 19, 2021. | Technology Services |
MedAvail, Inc.
 MedAvail, Inc. Information Technology ServicesTechnology Services MedAvail, Inc. operates as a technology-enabled pharmacy organization. The firm offers turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations, to Medicare clinics. The company was founded in 2012 and is headquartered in Phoenix, AZ. | Technology Services |
| Tanenbaum Open Science Institute | |
VIDA FLaSH Acquisitions
VIDA FLaSH Acquisitions Financial ConglomeratesFinance VIDA FLaSH Acquisitions operates as a development stage company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded by Frank Litvack and Scott R. Huennekens on January 29, 2021 and is headquartered in Los Angeles, CA. | Finance |
Levation Pharma Ltd.
 Levation Pharma Ltd. Medical DistributorsDistribution Services Levation Pharma Ltd. distributes pharmaceutical products. The company is based in Tel Aviv, Israel. The Israeli company was founded in 2017 by Frank Litvack. | Distribution Services |
